News

Publish Date
USPTO Updates Eligibility Guidance for AI: ‘We Want to Accelerate AI Innovation Without Locking it Up’
IPWatchdog
Elieen McDermott and Gene Quinn
Drug Pricing, Overreach Dominate IP Disclaimer Feedback
Law360
Dani Kass
FTC Backs USPTO Terminal Disclaimer NPRM as Others Warn it Exceeds Agency Authority
IPWatchdog
Eileen McDermott
USPTO’s AI-Assisted Inventions Guidance Irks ABA IP Section
Law360
Hannah Albarazi
Patent Owners, Challengers Spar Over PTAB Rule Proposal
Law360
Ryan Davis
USPTO Hears Array Of Ideas For Altering Director Review
Law360
Ryan Davis
USPTO Extends Deadline for AI Inventorship Comments as Some Criticize Pannu Factors
IPWatchdog
Steve Brachmann
Organizations Tell USPTO Proposed 2025 Fees ‘Misuse’ Office’s Fee Setting Authority
IPWatchdog
Eileen McDermott
As Senate’s gaze lands on patents, a former US PTO chief calls the effort a ‘broad misunderstanding’
PharmaVoice
Michael Gibney
Former USPTO Officials Urge Vidal to Immediately Withdraw NPRM on Terminal Disclaimers
IPWatchdog
Steve Brachmann
Ex-USPTO Directors Want Vidal To Withdraw Disclaimer Plans
Law360
Hailey Konnath
Quintet of Ex-Patent Office Officials Slam Proposed Rulemaking
Bloomberg Law
Michael Shapiro
Scroll to Top